AES CORP. DL-,01/ US00130H1059 /
| 10/11/2024 17:16:02 | Var. +0.010 | Volume | Denaro17:16:02 | Lettera17:16:02 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
|---|---|---|---|---|---|---|---|
| 12.680EUR | +0.08% | - Fatturato: - |
12.680Quantità in denaro: - | 12.780Quantità in lettera: - | 9.02 bill.EUR | - | - |
Newsfile Corp
29/10
Perseverance Metals Announces New Critical Mineral Discoveries from the Lac Gayot Nickel-Copper-PGE ...
Newsfile Corp
19/09
Perseverance Metals Discovers New Nickel Zone, Yields 1.82% NiEq over 5.1 Meters at Lac Gayot Projec...
Newsfile Corp
17/09
Endurance Announces First 2024 Drill Results At The Reliance Gold Project, BC; Initial Six Holes Exp...
GlobeNewswire
30/08
IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizu...
GlobeNewswire
28/08
Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Port...
Newsfile Corp
26/08
ALX Resources Corp. Completes Prospecting and Sampling Programs at the Cannon Copper Project, Ontari...
GlobeNewswire
22/08
Cognition Therapeutics Publishes EEG Findings from Phase 2 SEQUEL Study of CT1812 in Mild-to-Moderat...
Newsfile Corp
20/08
Appia Confirms Outstanding Desorption Results From Its Ionic Adsorption Clay Targets Maia, Electra, ...
GlobeNewswire
15/08
Great Place To Work® Announces the 2024 Best Workplaces in Latin America Representing 3.8 Million Em...
GlobeNewswire
14/08
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic...
GlobeNewswire
14/08
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
12/08
Avalyn Announces Initiation of Phase 1b Clinical Study for AP02, its Novel Inhaled Nintedanib
GlobeNewswire
12/08
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at...
GlobeNewswire
08/08
Apellis and Sobi Announce Positive Topline Results from Phase 3 VALIANT Study of Pegcetacoplan in C3...
